comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 15:27:43 - browse：3382

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Petition to FDA: Get the lead out of consumer hair dyes

focus

WSS

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Beach reads and more: STAT's 2023 summer book list

Study: Pain burden is higher in Black NFL players than white ones

Flagship Pioneering launches a new biotech in two countries

Despite FDA concern, risk that CAR

Charles Manson follower Leslie Van Houten released from prison after 53 years

focus

comprehensive

hotspot

Cancer drug shortages should be causing more outrage

Iowa House, Senate pass 6

Supreme Court strikes down use of affirmative action

Pediatric cancer treatments threatened by a new FDA policy

Dobbs anniversary: the lost opportunity of abortion as health care

How the political right came to back psychedelics to treat trauma

Activists slam private health insurers over coverage restrictions

U.K. Biobank has 500,000 peoples' genome sequences available

In Memoriam: Notable people who died in 2023

Organ aging and disease risk measured by new blood test

Wikipedia

It's time to get medical device identifiers over the finish line

A new study sees potential in DNA sequencing of infants

J&J to emphasize cancer drugs, stop much of its vaccine research

UnitedHealth’s Optum accused of antitrust violations in California

The EPA's new lead rule: How one expert crunched the numbers

Why 40% Americans with Parkinson’s don’t see a neurologist

focus

focus

Wikipedia

hotspot